Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-Arrhythmia Agents

Known as: antiarrhythmia, Anti-arrhythmic Agent [TC], Antiarrhythmic 
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
ACCF : American College of Cardiology Foundation ACCP : American College of Chest Physicians ACS : acute coronary syndrome ACT… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 4
Review
2010
Review
2010
Background—The purpose of this study was to provide an updated worldwide report on the methods, efficacy, and safety of catheter… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2007
Highly Cited
2007
MicroRNAs (miRNAs) are endogenous noncoding RNAs, about 22 nucleotides in length, that mediate post-transcriptional gene… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2005
Review
2005
Background—The purpose of this study was to conduct a worldwide survey investigating the methods, efficacy, and safety of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2002
Highly Cited
2002
The current update of the ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices includes… Expand
  • figure 1
  • figure 2
  • table 2
Highly Cited
2002
Highly Cited
2002
BACKGROUND Maintenance of sinus rhythm is the main therapeutic goal in patients with atrial fibrillation. However, recurrences of… Expand
  • figure 1
  • figure 2
  • table 3
Highly Cited
2002
Highly Cited
2002
Background—The pulmonary veins (PVs) have been demonstrated to often play an important role in generating atrial fibrillation (AF… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Highly Cited
1999
Highly Cited
1999
BACKGROUND Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and… Expand
Highly Cited
1997
Highly Cited
1997
BACKGROUND Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be… Expand
Highly Cited
1990
Highly Cited
1990
Homogeneity of recovery time protects against arrhythmias whereas dispersion of recovery time is arrhythmogenic. A single surface… Expand